Form 4: Editas Medicine EVP Linda Burkly Sells Shares to Cover Tax Obligations

EVP and Chief Scientific Officer of Editas Medicine, Linda Burkly, sold 11,886 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• Linda Burkly, EVP and Chief Scientific Officer of Editas Medicine, sold 11,886 shares of Editas Medicine common stock on July 25, 2024.
• The shares were sold at a price of $5.4156 per share.
• The sale was executed to cover tax withholding obligations resulting from the vesting of restricted stock units on July 24, 2024.
• The sale was conducted under a pre-arranged automatic sales plan adopted on July 3, 2023.
• Following the transaction, Burkly directly owns 73,136 shares of Editas Medicine.

Sentiment

Score: 5

Explanation: The document describes a routine stock sale to cover tax obligations, which is neither particularly positive nor negative. It's a neutral event.

Industry Context

Sales to cover tax obligations are a common practice among company executives receiving equity compensation. This transaction is not necessarily indicative of the executive's sentiment towards the company's future prospects.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the stated reason for the sale.

Key Dates